Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726921 · ClinicalTrials.gov registry record
Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 189
- Enrollment target
NCT00726921 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 189 participants.
The verdict
NCT00726921 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 189 participants
- Enrollment target
Study Summary
This study investigates hypothesizes that the combination of dobutamine stress echocardiography with dobutamine stress echocardiography with real time perfusion myocardial contrast echocardiography and coronary computed tomography is a better modality for detecting coronary artery disease in end-stage renal disease patients than coronary angiography, and in predicting patient outcomes. Demonstrating this would lead to increased use of DSE with RTCE and coronary CT at kidney transplant centers throughout the nation, leading to improved anatomical and functional detection of CAD without the need for further invasive procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2008-08-25 |
| Est. Completion | 2012-12-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00726921
The ClinicalTrials.gov registry entry for NCT00726921 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00726921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00726921 about?
NCT00726921 is a clinical study titled "Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients". This study investigates hypothesizes that the combination of dobutamine stress echocardiography with dobutamine stress echocardiography with real time perfusion myocardial contrast echocardiography and coronary computed tomography is a better modality for detecting coronary artery disease in end-sta...
What is the current status of trial NCT00726921?
This trial is currently completed. The enrollment target is 189 participants. The study started on 2008-08-25. Estimated completion is 2012-12-21.
Who is sponsoring clinical trial NCT00726921?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.